Share Name Share Symbol Market Type Share ISIN Share Description
Proteome LSE:PRM London Ordinary Share GB0003104196 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25p -5.88% 4.00p 3.76p 4.50p 4.00p 4.00p 4.00p 350,000.00 11:59:50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 2.8 -2.9 -1.0 - 11.77

Proteome Share Discussion Threads

Showing 174751 to 174774 of 174775 messages
Chat Pages: 6991  6990  6989  6988  6987  6986  6985  6984  6983  6982  6981  6980  Older
DateSubjectAuthorDiscuss
28/3/2017
13:03
Well if we do get the TauRx and Randox milestone payments this year.. that's a few million eh!!
glennrcharles
28/3/2017
12:53
Looking at the marked trades page, it looks like they are saving up the bad news until nearer the close of play today.
badger60
28/3/2017
12:47
Placed yer bet yet stocky?
badger60
28/3/2017
12:46
'I just assumed that as PRM were neither willing nor able to carry on development of ck1d themselves ("treatment potential of these inhibitors has yet to be assessed and is not something we are equipped to undertake ourselves") a disposal fitted in better with the "pruning" word used by Haigh.' jeffian Outlicensing seems most likely. Easier to arrive at a price that suits both vs outright sale, since the upside can be covered by milestones. Read 'pruning' as 'not investing in further' - which was fairly clear and mandatory anyway, even if Pike and others referred to other studies as if PRM could do so!
stocktastic
28/3/2017
12:43
#69404 BOL! What a complete and utter end.
saul goodman
28/3/2017
12:43
"saul goodman28 Mar '17 - 09:37 - 69367 of 69402 0 0 No mention of the disappointing retention rate of customers or the unexpected drop off in sales/contracts in H2 in certain areas at all?" No golly, because we knew that already. Nobody expected the retention rate to be good - Haigh had already flagged it as not good enough and something he has been focusing on to fix. It's amusing that you're too weak a man to acknowledge you were wrong in how you interpreted the earlier Haigh interview re CK1d. The 'big man' who is so so protective little bb usernames. A spineless parasite
stocktastic
28/3/2017
12:43
You mean like circa -£3mio from profitability.....
badger60
28/3/2017
12:38
Glen, PRM won't be too far from profitability THIS YEAR.
pools2
28/3/2017
12:38
.......If it's Diggle there may well be a few more to go before he's finished selling..........
badger60
28/3/2017
12:35
Pools2 great.... awash with money then lol... have a great day... and get that seller out the way...
glennrcharles
28/3/2017
12:31
Aye, "definitely".
saul goodman
28/3/2017
12:29
Glen, TaxRx money is definitely arriving THIS YEAR.
pools2
28/3/2017
12:27
Re Ck1d.. the further developments in q2 may or may not be a deal. What else might they be? Anyone notice that it appears we may be getting the TauRx deal money this year. At least they refer to 3 payments. . Pity they couldn't talk this up a tad more. .. but the half full glass looks ok in the sun...
glennrcharles
28/3/2017
12:18
Indeed blue. My thoughts exactly. .. so anyone have an inkling which euro pharmaceutical is interested in alzheimers?
glennrcharles
28/3/2017
12:14
Did you know that the Cylons in the tv series Battlestar Galactica were created using genetically modified material from Monkman's, a contestant on UC, family? Or maybe it was the other way round?
badger60
28/3/2017
11:33
StockyDo yourself a favour. Give bet 365 a bell, give 'em a time (soon) for the first sub 4p trade, and go and sell a few at the appropriate moment. If you can do that with all your 8mio+ down to 0pps you my well get a few bob back from your horrendous losses here.
badger60
28/3/2017
11:32
#69390, Well either way we get value for it, blue. I just assumed that as PRM were neither willing nor able to carry on development of ck1d themselves ("treatment potential of these inhibitors has yet to be assessed and is not something we are equipped to undertake ourselves") a disposal fitted in better with the "pruning" word used by Haigh. If he used it!
jeffian
28/3/2017
11:27
I must confess to not having read the report; I'm more than happy to rely on the interpretation posted by the outstanding avatar jeffian.
avatar333
28/3/2017
11:24
The report is excellent, imo. There is quite literally something in it for everyone. For those locked in and in desperate need of a turnaround in fortunes, the distant hopes and dreams of some sort of mystical route to profitability remains just around the corner. For everyone else there is confirmation that it is still a POS.
saul goodman
28/3/2017
11:14
No.... It's a kind way of saying binning it.....
badger60
28/3/2017
11:14
Will we see the Ck1d deal in the next quarter, as the RNS suggests? We know the first Stroke blood test is being released by then! Etc etc etc Could be an interesting 3 months! :)
pools2
28/3/2017
11:10
#69386 If by "selling it" you mean in discussions to out-licence Ck1d, then of course they are, this was always the intention, even pre-Haigh.
bluemango
28/3/2017
11:09
StockyBet365 are making odds on the time print for the first sub 4pps trade today. Get yourself down there and fill yer boots!
badger60
28/3/2017
11:04
69386 All duly noted, with thanks, jeffian.
avatar333
Chat Pages: 6991  6990  6989  6988  6987  6986  6985  6984  6983  6982  6981  6980  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20170328 12:08:11